7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxaMide;1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxamide;phenyl(4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-;4-hydroxy-7Chemicalbook-methoxyquinoline-6-carboxamide;lenvaim-C;LenvatinibImpurity19;6-Quinolinecarboxamide,1,4-dihydro-7-methoxy-4-oxo-;7-methoxy-4-oxo-1,4-dihydro-6-quinolinecarboxamide
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Lombartinib Impurity 22 is a critical synthetic intermediate and reference standard for the pharmaceutical manufacturing of Lombartinib, a targeted tyrosine kinase inhibitor. Produced via <strong>high-purity organic synthesis</strong>, this compound serves as an essential quality control material to ensure drug purity and regulatory compliance. The molecular formula is <strong>C20H19ClN4O2</strong> with CAS No. <strong>287568-58-3</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical R&D:</strong> Used in method development and validation for HPLC/MS analysis.</li>
<li><strong>Quality Control:</strong> Serves as a certified reference standard for identifying and quantifying impurities.</li>
<li><strong>Regulatory Submissions:</strong> Provides data for IND and NDA filings regarding genotoxicity profiles.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly store at <strong>-20°C</strong> under inert atmosphere to prevent degradation. Handling requires appropriate PPE including gloves and goggles due to potential mutagenic risks associated with chemical intermediates. Not intended for direct clinical administration.</p>